Benitec Biopharma Inc. (BNTC)
NASDAQ: BNTC · Real-Time Price · USD
14.10
+0.32 (2.32%)
At close: Oct 8, 2025, 4:00 PM EDT
14.10
0.00 (0.00%)
After-hours: Oct 8, 2025, 4:04 PM EDT

Benitec Biopharma Cash Flow Statement

Millions USD. Fiscal year is Jul - Jun.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 20212016 - 2020
Period Ending
Jun '25 Jun '24 Jun '23 Jun '22 Jun '21 2016 - 2020
Net Income
-37.92-21.75-19.56-18.21-13.88
Upgrade
Depreciation & Amortization
0.40.340.380.390.42
Upgrade
Loss (Gain) From Sale of Investments
-000.01-0.02
Upgrade
Stock-Based Compensation
17.430.830.450.870.63
Upgrade
Other Operating Activities
-0.76----
Upgrade
Change in Accounts Receivable
0.2-0.18-0.0500.03
Upgrade
Change in Accounts Payable
-2.380.941.361.090.06
Upgrade
Change in Other Net Operating Assets
-0.550.41-0.59-0.05-0.08
Upgrade
Operating Cash Flow
-23.59-19.4-18.01-15.9-12.83
Upgrade
Capital Expenditures
-0.02-0.18-0-0.01-0.22
Upgrade
Investing Cash Flow
-0.02-0.18-0-0.01-0.22
Upgrade
Issuance of Common Stock
72.873.9217.88-25.75
Upgrade
Other Financing Activities
-2.32-5.89-1.87--3.23
Upgrade
Financing Cash Flow
70.4968.0316.02-22.52
Upgrade
Foreign Exchange Rate Adjustments
0.05-0.010.410.20.5
Upgrade
Net Cash Flow
46.9348.44-1.59-15.719.97
Upgrade
Free Cash Flow
-23.61-19.58-18.01-15.91-13.05
Upgrade
Free Cash Flow Margin
---24017.33%-21797.26%-22123.73%
Upgrade
Free Cash Flow Per Share
-0.65-1.07-13.00-33.10-51.66
Upgrade
Levered Free Cash Flow
-11.46-11.68-10.19-8.72-7.28
Upgrade
Unlevered Free Cash Flow
-11.46-11.68-10.16-8.7-7.28
Upgrade
Change in Working Capital
-2.731.170.711.040.01
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q